日本高潮视频在线观看-亚洲中文字幕永不卡-精品亚洲一区二区三区-伦理片夜夜躁狠狠躁日日躁-日本最新免费不卡二区-国产精品口爆一区二区三区-av一区二区三区高清-大鸡巴疯狂抽插小穴视频-日韩中文国产在线观看免费视频

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Salmo salar Choline transporter-like protein 2 (slc44a2), partial CSB-YP021649SWI
CSB-EP021649SWI
CSB-BP021649SWI
CSB-MP021649SWI
CSB-EP021649SWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmo salar DNA repair protein SWI5 homolog (swi5) CSB-YP004274SWI
CSB-EP004274SWI
CSB-BP004274SWI
CSB-MP004274SWI
CSB-EP004274SWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Salmo salar Trafficking protein particle complex subunit 2-like protein (trappc2l) CSB-YP024228SWI
CSB-EP024228SWI
CSB-BP024228SWI
CSB-MP024228SWI
CSB-EP024228SWI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Thymidylate kinase (tmk) CSB-YP007226FNH
CSB-EP007226FNH
CSB-BP007226FNH
CSB-MP007226FNH
CSB-EP007226FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 GTPase Era (era) CSB-YP007759FNH
CSB-EP007759FNH
CSB-BP007759FNH
CSB-MP007759FNH
CSB-EP007759FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 ATP synthase subunit b (atpF), partial CSB-YP002358FNH1
CSB-EP002358FNH1
CSB-BP002358FNH1
CSB-MP002358FNH1
CSB-EP002358FNH1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Streptococcus pyogenes serotype M49 Peptide chain release factor 1 (prfA) CSB-YP015197FNH
CSB-EP015197FNH
CSB-BP015197FNH
CSB-MP015197FNH
CSB-EP015197FNH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Peptide deformylase (def) CSB-YP017707KBH
CSB-EP017707KBH
CSB-BP017707KBH
CSB-MP017707KBH
CSB-EP017707KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Argininosuccinate synthase (argG) CSB-YP002234KBH
CSB-EP002234KBH
CSB-BP002234KBH
CSB-MP002234KBH
CSB-EP002234KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae 3-ketoacyl-CoA thiolase (fadI) CSB-YP001117KBH
CSB-EP001117KBH
CSB-BP001117KBH
CSB-MP001117KBH
CSB-EP001117KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Porphobilinogen deaminase (hemC) CSB-YP010524KBH
CSB-EP010524KBH
CSB-BP010524KBH
CSB-MP010524KBH
CSB-EP010524KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Enolase-phosphatase E1 (mtnC) CSB-YP007674KBH
CSB-EP007674KBH
CSB-BP007674KBH
CSB-MP007674KBH
CSB-EP007674KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae Elongation factor Ts (tsf) CSB-YP025124KBH
CSB-EP025124KBH
CSB-BP025124KBH
CSB-MP025124KBH
CSB-EP025124KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Klebsiella pneumoniae S-adenosylmethionine decarboxylase proenzyme (speD) CSB-YP001658KBH
CSB-EP001658KBH
CSB-BP001658KBH
CSB-MP001658KBH
CSB-EP001658KBH-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coprothermobacter proteolyticus Thymidylate kinase (tmk) CSB-YP007226DWR
CSB-EP007226DWR
CSB-BP007226DWR
CSB-MP007226DWR
CSB-EP007226DWR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Coprothermobacter proteolyticus tRNA pseudouridine synthase A (truA) CSB-YP019086DWR
CSB-EP019086DWR
CSB-BP019086DWR
CSB-MP019086DWR
CSB-EP019086DWR-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyoglomus thermophilum ATP synthase subunit b (atpF), partial CSB-YP002358DKI1
CSB-EP002358DKI1
CSB-BP002358DKI1
CSB-MP002358DKI1
CSB-EP002358DKI1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dictyoglomus thermophilum tRNA pseudouridine synthase A (truA) CSB-YP019086DKI
CSB-EP019086DKI
CSB-BP019086DKI
CSB-MP019086DKI
CSB-EP019086DKI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermodesulfovibrio yellowstonii Translation initiation factor IF-2 (infB), partial CSB-YP015164TMY
CSB-EP015164TMY
CSB-BP015164TMY
CSB-MP015164TMY
CSB-EP015164TMY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Thermodesulfovibrio yellowstonii Queuine tRNA-ribosyltransferase (tgt) CSB-YP019146TMY
CSB-EP019146TMY
CSB-BP019146TMY
CSB-MP019146TMY
CSB-EP019146TMY-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.bdspa.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>



×